PSP Research »

Incyte Corporation shares owned by PSP Research

Quarter-by-quarter ownership of Incyte Corporation (INCY) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Incyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Incyte Corporation held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Incyte Corporation by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $528k 5.4k 98.77

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Incyte Corporation

Baker Bros. Advisors
Vanguard Group
BlackRock
Dodge & Cox
State Street Corporation
AQR Capital Management
Geode Capital Management
Renaissance Technologies
LSV Asset Management
Invesco
Arrowstreet Capital, Limited Partnership
Robeco Institutional Asset Management B V
Thomas Stevens, CFA"
Jacobs Levy Equity Management
Acadian Asset Management

View all funds holding Incyte Corporation